Literature DB >> 19038736

Continuous-flow rotary left ventricular assist devices with "3rd generation" design.

Francis D Pagani1.   

Abstract

Left ventricular assist device (LVAD) therapy has become an established treatment option for patients with advanced heart failure. Broader application of this therapy has been limited by the risk profile of the current generation of devices. The development of continuous-flow rotary pump technology with noncontact bearing design offers the promise of improved device durability and safety profile. Clinical evaluation of these innovative pump designs are currently underway.

Entities:  

Mesh:

Year:  2008        PMID: 19038736     DOI: 10.1053/j.semtcvs.2008.08.002

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  14 in total

1.  CrossTalk proposal: Blood flow pulsatility in left ventricular assist device patients is essential to maintain normal brain physiology.

Authors:  Eric J Stöhr; Barry J McDonnell; Paolo C Colombo; Joshua Z Willey
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

2.  Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantation.

Authors:  Matteo Pozzi; Raphaël Giraud; Piergiorgio Tozzi; Karim Bendjelid; Jacques Robin; Philippe Meyer; Jean François Obadia; Carlo Banfi
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 3.  Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.

Authors:  Thomas C Hanff; Edo Y Birati
Journal:  Curr Heart Fail Rep       Date:  2019-10

4.  Hematologic effects of continuous flow left ventricular assist devices.

Authors:  Mark S Slaughter
Journal:  J Cardiovasc Transl Res       Date:  2010-09-11       Impact factor: 4.132

Review 5.  Ventricular assist devices: history, patient selection, and timing of therapy.

Authors:  Daniel G Tang; Philip E Oyer; Hari R Mallidi
Journal:  J Cardiovasc Transl Res       Date:  2009-03-19       Impact factor: 4.132

6.  Transapical miniaturized ventricular assist device: design and initial testing.

Authors:  Mark S Slaughter; Guruprasad A Giridharan; Dan Tamez; Jeff LaRose; Mike A Sobieski; Leslie Sherwood; Steven C Koenig
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02-12       Impact factor: 5.209

7.  Effects of Acute Pump Speed Changes on Cerebral Hemodynamics in Patients With an Implantable Continuous-Flow Left Ventricular Assist Devices.

Authors:  M Konarik; M Sramko; Z Dorazilova; M Blaha; I Netuka; P Ivak; J Maly; O Szarszoi
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

Review 8.  Emerging ventricular assist devices for long-term cardiac support.

Authors:  Rajan Krishnamani; David DeNofrio; Marvin A Konstam
Journal:  Nat Rev Cardiol       Date:  2010-01-12       Impact factor: 32.419

9.  Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Christine Sailer; Hannah Edelmann; Cullen Buchanan; Pedro Giro; Matthew Babcock; Christine Swanson; Melanie Spotts; Margaret Schulte; Ashley Pratt-Cordova; Greg Coe; Mark Beindorff; Robert L Page; Amrut V Ambardekar; Jay D Pal; Wendy Kohrt; Eugene Wolfel; Justin S Lawley; Takashi Tarumi; William K Cornwell
Journal:  Circ Heart Fail       Date:  2021-01-19       Impact factor: 8.790

Review 10.  Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge.

Authors:  Nicolò Sisti; Amato Santoro; Giovanni Carreras; Serafina Valente; Stefano Donzelli; Giulia Elena Mandoli; Carlotta Sciaccaluga; Matteo Cameli
Journal:  J Arrhythm       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.